Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office in Tokyo. The preliminary agreement was signed last November.
ASKA will hold 55% of shares in the joint venture; Actavis 45%. The joint company intends to enter the Japanese generic pharmaceutical market in April [...]
Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office in Tokyo. The preliminary agreement was signed last November.
ASKA will hold 55% of shares in the joint venture; Actavis 45%. The joint company intends to enter the Japanese generic pharmaceutical market in April [...]
This entry was posted
on Thursday, April 2nd, 2009 at 3:31 pm and is filed under Iceland.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.